NEW YORK (GenomeWeb News) – Identitas and Akesogen today announced a commercial partnership they said will allow forensics investigators "to generate more comprehensive leads from DNA samples than had previously been possible."

The companies have entered into a licensing deal providing Akesogen access to Identitas' ISAS software, which interrogates SNPs for a profile that describes the physical appearance of an individual. Akesogen will offer an end-to-end genetic analysis package powered by ISAS.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.